ResearcherTongji UniversityNo recent work listed

Bo Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2216-2794; OpenAlex author ID A5100427315. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper

Papers 2

Upregulation of DLC-1 inhibits pancreatic cancer progression: Studies with clinical samples and a pancreatic cancer model. Co-author DOI 10.3892/ol.2019.10871 ↗
Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling. Co-author DOI 10.1002/jcp.26357 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ming Xu · 1 shared paper, 2019 · strength 0.16
- Paper Upregulation of DLC-1 inhibits pancreatic cancer progression: Studies with clinical samples and a pancreatic cancer mod… DOI 10.3892/ol.2019.10871 ↗
Zhiyuan Hua · 1 shared paper, 2018 · strength 0.09
- Paper Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling. DOI 10.1002/jcp.26357 ↗
Tu Dai · 1 shared paper, 2018 · strength 0.09
- Paper Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling. DOI 10.1002/jcp.26357 ↗
Yongping Zhou · 1 shared paper, 2018 · strength 0.09
- Paper Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling. DOI 10.1002/jcp.26357 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.